October 19, 2021 (Fagali’i, American Samoa) – This past Sunday, October 17, 2021, the American Samoa Department of Health, with support from the Centers for Disease Control and Prevention, World Health Organization, and PIHOA, kicked off the third round of the Mass Drug Administration (MDA) for Lymphatic Filariasis (LF) at the Nu’uuli Methodist Church. This week, DOH teams began their village outreach on the westside, starting with the villages of Fagamalo and Fagali’i. LF is a vector-borne neglected tropical disease that causes damage to the lymphatic system and can lead to lymphedema and hydrocele in infected individuals. The medication regimen is provided to all eligible persons in the community to interrupt the transmission of LF. American Samoa is in its third year of the LF MDA initiative to eliminate the disease as a public health issue in the island nation.
American Samoa launches third round of the Lymphatic Filariasis Mass Drug Administration
